Prenatal Screening Guide

NIPT vs Quadruple Screening: Which Prenatal Test Is Right for You? Accuracy, Timing, Cost, and Real-World Differences Compared

NIPT and quadruple screening both assess risk for chromosomal conditions in pregnancy but differ in accuracy, timing, cost, and what they measure. This guide compares them clearly so you can choose wisely.

Medically Reviewed Content

Reviewed by: Thamel Clinic Clinical Team (MBBS, MD)

Last medical review: November 8, 2026

Next scheduled review: May 8, 2027

This content follows evidence-based medical guidelines and is regularly updated to reflect current medical practices.

Prenatal Screening in Nepal

  • Growing availability — NIPT is increasingly available in Kathmandu through private laboratories, though access outside the Valley remains limited.
  • Cost difference matters — quadruple screening costs a fraction of NIPT (typically Rs. 2,000–4,000 vs Rs. 15,000–40,000), making it the accessible option for many families.
  • Public health context — Nepal's maternal health programs emphasize accessible screening; quad screen remains the standard in many public facilities.
  • Genetic counseling limited — fewer genetic counselors exist in Nepal than in high-income countries, making clear patient education about test limitations especially important.
  • Diagnostic follow-up — confirmatory testing through amniocentesis or CVS is available in Kathmandu for women with positive screening results.

Two Approaches to Prenatal Screening

Prenatal screening tests estimate the chance that a pregnancy is affected by certain chromosomal conditions — most commonly Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13). Both NIPT and quadruple screening serve this purpose, but they work in fundamentally different ways, detect different conditions with different accuracy, and suit different situations and budgets.

The quadruple screen — also called the quad screen or second-trimester screen — is a blood test performed between 15 and 20 weeks of pregnancy that measures four substances in the mother's blood: alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), unconjugated estriol, and inhibin A. These markers correlate with chromosomal conditions and open neural tube defects. It is a screening test only — it estimates risk but cannot diagnose.

NIPT — non-invasive prenatal testing — analyzes cell-free fetal DNA circulating in the mother's blood to directly assess the baby's chromosomes. Available from around 10 weeks, it screens for trisomy 21, 18, and 13 with much higher accuracy than the quad screen, and can optionally test for sex chromosome conditions and microdeletions. Like the quad screen, it is screening not diagnosis — positive results require confirmatory testing.

This page compares NIPT and quadruple screening across accuracy, timing, cost, what they detect, limitations, and who each suits best. It also covers when neither test is enough, when diagnostic testing like amniocentesis is needed, and how to discuss options with your doctor in Kathmandu.

How NIPT and Quadruple Screening Work

The quadruple screen measures four proteins and hormones produced by the placenta and fetus that enter the mother's bloodstream. Elevated or reduced levels of these markers correlate statistically with chromosomal abnormalities and neural tube defects. The test compares your results against population averages adjusted for your age, weight, gestational age, and sometimes ethnicity to estimate risk.

NIPT takes a different approach entirely. During pregnancy, small fragments of fetal DNA — shed from the placenta — circulate in the mother's blood mixed with her own DNA. NIPT sequences this cell-free DNA and measures the proportion of chromosomes coming from the fetus. If the fetus has an extra copy of chromosome 21, 18, or 13, the fetal DNA fraction shows that imbalance, allowing highly accurate detection of trisomies.

  • Quad screen: blood test at 15–20 weeks measuring AFP, hCG, estriol, and inhibin A.
  • NIPT: blood test from ~10 weeks analyzing cell-free fetal DNA for chromosomal imbalances.
  • Quad screen detects risk statistically; NIPT measures fetal chromosomes directly.
  • Both are screening tests — neither provides a definitive diagnosis.
  • Quad screen also detects open neural tube defects; standard NIPT does not.

Quadruple Screen

A second-trimester blood test measuring four placental and fetal markers to estimate risk of trisomies and neural tube defects.

NIPT

A first-trimester blood test analyzing fetal DNA fragments to directly assess chromosomal balance with high accuracy.

What They Share

Both are screening tests that estimate risk — neither is diagnostic, and positive results always need confirmatory testing.

Key Difference

Quad screen infers risk from protein levels; NIPT directly measures fetal chromosomes — fundamentally different technologies.

Accuracy: The Biggest Difference

NIPT is dramatically more accurate than quadruple screening for detecting trisomy 21. For Down syndrome, NIPT has detection rates above 99% with false positive rates below 0.1% in most studies. The quadruple screen detects about 80% of Down syndrome cases with a 5% false positive rate — meaning many more women are told they are high-risk and referred for unnecessary diagnostic procedures.

For trisomy 18 and 13, NIPT similarly outperforms the quad screen substantially. However, NIPT is not perfect — it has slightly lower accuracy for sex chromosome conditions and microdeletions, and rare false positives and false negatives occur. The quad screen's advantage is that it also detects open neural tube defects through AFP, which standard NIPT does not screen for.

  • NIPT detects >99% of trisomy 21 cases with <0.1% false positive rate.
  • Quad screen detects ~80% of Down syndrome with ~5% false positive rate.
  • NIPT is more accurate for trisomies 18 and 13 as well.
  • NIPT is less accurate for sex chromosome conditions and microdeletions.
  • Quad screen detects neural tube defects; standard NIPT does not.
  • Both require confirmatory diagnostic testing for positive results.

Down Syndrome Detection

NIPT catches nearly all cases; quad screen misses about 1 in 5. This difference drives most patients toward NIPT when affordable.

False Positive Rates

NIPT's <0.1% false positive rate versus quad screen's ~5% means far fewer women need invasive follow-up testing.

Neural Tube Defects

The quad screen detects open neural tube defects through AFP — a capability standard NIPT lacks, though ultrasound anatomy scans also screen for these.

Neither Is Perfect

Both tests can produce false results — positive results always need confirmatory amniocentesis or CVS before any diagnosis.

Timing, Availability, and Access in Nepal

NIPT can be performed from approximately 10 weeks of pregnancy — earlier than the quad screen which is done at 15–20 weeks. Earlier results mean earlier decisions and less prolonged anxiety. NIPT requires only a maternal blood draw, just like the quad screen, and results typically take one to two weeks.

In Nepal, quadruple screening is more widely available and significantly cheaper — typically Rs. 2,000–4,000 versus NIPT at Rs. 15,000–40,000 depending on the panel. Quad screening is available at most hospitals and laboratories; NIPT is primarily offered by private laboratories in Kathmandu with samples sometimes sent to reference labs abroad. Access outside Kathmandu remains limited for both, though quad screen is more accessible.

  • NIPT available from ~10 weeks; quad screen at 15–20 weeks.
  • NIPT results typically in 1–2 weeks; quad screen similar timeframe.
  • Quad screen: Rs. 2,000–4,000 — widely available across Nepal.
  • NIPT: Rs. 15,000–40,000 — primarily Kathmandu private laboratories.
  • Both require only a maternal blood sample — no special preparation.
  • NIPT may require higher fetal fraction — may need repeat draw if insufficient fetal DNA.

Earlier Testing

NIPT from 10 weeks gives results months earlier than quad screen — valuable for families wanting earlier information.

Cost Reality

Quad screen costs a fraction of NIPT — for many Nepali families, this is the deciding factor.

Availability

Quad screen is available at most facilities; NIPT is concentrated in Kathmandu private labs.

Same Sample Type

Both tests use a simple maternal blood draw — the difference is what the laboratory analyzes.

Choosing Between NIPT and Quadruple Screening

The choice depends on your priorities, budget, and risk factors. NIPT is the better test medically — higher accuracy, earlier timing, lower false positive rate — for families who can afford it and want the most reliable screening. It is particularly valuable for women over 35, those with a previous pregnancy affected by chromosomal conditions, or those who want comprehensive screening including sex chromosome conditions.

Quadruple screening remains an excellent choice for many women — it is affordable, widely available, detects neural tube defects that NIPT misses, and provides reasonable risk assessment for those at average risk. For women at low risk who want screening but cannot afford NIPT, the quad screen offers good value. Some women choose both — NIPT for chromosomal conditions and ultrasound anatomy scan for structural abnormalities including neural tube defects.

  • Choose NIPT if: you can afford it, want highest accuracy, are over 35, or have risk factors.
  • Choose quad screen if: budget is a concern, you want neural tube defect screening, or NIPT is unavailable.
  • Consider both NIPT and detailed ultrasound for comprehensive screening.
  • Your doctor can help decide based on your age, history, and preferences.
  • Neither replaces diagnostic testing — positive results need amniocentesis or CVS.

NIPT Best For

Women over 35, those with previous affected pregnancies, families wanting highest accuracy, and those who can afford the premium.

Quad Screen Best For

Budget-conscious families, those wanting neural tube defect screening, average-risk pregnancies, and areas where NIPT is unavailable.

Combined Approach

NIPT for chromosomal screening plus detailed ultrasound anatomy scan for structural abnormalities gives comprehensive coverage.

Ask Your Doctor

Your obstetrician can recommend the best option based on your specific risk factors, gestational age, and circumstances.

Costs and What Happens After Screening

In Kathmandu, quadruple screening typically costs Rs. 2,000–4,000 while NIPT ranges Rs. 15,000–40,000 depending on the panel — basic trisomy screening at the lower end, expanded panels including sex chromosomes and microdeletions at the higher end. Confirmatory diagnostic testing through amniocentesis or CVS costs additional Rs. 15,000–30,000 and carries a small procedure-related risk.

After screening, a low-risk result provides reassurance but does not eliminate all risks — detailed ultrasound anatomy scans remain important. A high-risk result does not mean the baby has a condition — it means further evaluation is needed through genetic counseling and possibly diagnostic testing. Understanding that screening is not diagnosis prevents both false reassurance and unnecessary panic.

  • Quad screen: Rs. 2,000–4,000 in Kathmandu.
  • NIPT basic panel: Rs. 15,000–25,000; expanded panels Rs. 25,000–40,000.
  • Diagnostic testing (amniocentesis/CVS): Rs. 15,000–30,000 plus procedure risk.
  • Low-risk results still need ultrasound anatomy scan for structural abnormalities.
  • High-risk results need genetic counseling and possible diagnostic confirmation.

Transparent Pricing

Both tests have clear pricing in Kathmandu — ask for the specific panel and what it includes before booking.

Screening Not Diagnosis

A high-risk result means further evaluation is needed, not that your baby has a condition — most high-risk results are false positives.

Follow-Up Pathway

Positive screening leads to genetic counseling and possibly amniocentesis or CVS for definitive diagnosis.

Complete Prenatal Care

Screening is one part of prenatal care — ultrasound scans, blood tests, and consultations work together for comprehensive monitoring.

Prenatal Screening Services and Prices

ServiceWhat It IncludesCost (NPR)
Quadruple Screening (Quad Screen)Second-trimester blood test at 15–20 weeks measuring AFP, hCG, estriol, and inhibin A.Rs. 2,000–4,000
NIPT — Basic PanelScreens for trisomy 21, 18, and 13 from ~10 weeks via cell-free fetal DNA.Rs. 15,000–25,000
NIPT — Expanded PanelAdds sex chromosome conditions and microdeletion screening.Rs. 25,000–40,000
Detailed Ultrasound Anatomy ScanStructural anomaly scan complementing biochemical screening.Rs. 3,000–8,000
Genetic CounselingSpecialist consultation interpreting screening results and discussing options.Rs. 1,500–3,000
Diagnostic Testing (Amniocentesis/CVS)Definitive diagnosis through invasive sampling — requires counseling and carries small risk.Rs. 15,000–30,000

Indicative NPR pricing in Kathmandu. Confirmatory diagnostic testing is additional.

Why Patients Choose Thamel Clinic

  • Both options available — quad screening and NIPT offered side by side so you can choose based on your needs and budget.
  • Clear explanation of differences — clinicians explain accuracy, timing, cost, and limitations in plain language.
  • Genetic counseling included — results are interpreted with expert guidance on what they mean and what comes next.
  • Complete prenatal pathway — screening connects to ultrasound, diagnostic testing, and ongoing prenatal care when needed.
  • Transparent Kathmandu pricing — clear costs for each test with no hidden fees.
  • Confidential service — all consultations and results are completely private.

Frequently Asked Questions

Which is more accurate — NIPT or quadruple screening?

NIPT is significantly more accurate for detecting Down syndrome (>99% detection, <0.1% false positive) compared to quad screen (~80% detection, ~5% false positive). NIPT is also more accurate for trisomy 18 and 13. However, quad screen detects neural tube defects that NIPT does not, and both require confirmatory testing for positive results.

How much do NIPT and quadruple screening cost in Kathmandu?

Quadruple screening typically costs Rs. 2,000–4,000. NIPT basic panels range Rs. 15,000–25,000 and expanded panels Rs. 25,000–40,000. Confirmatory diagnostic testing through amniocentesis or CVS costs an additional Rs. 15,000–30,000. Prices vary by laboratory and panel.

When should I get NIPT versus quad screen?

NIPT can be done from ~10 weeks and quad screen at 15–20 weeks. If you want the earliest and most accurate screening and can afford it, choose NIPT. If budget is a concern or you want neural tube defect screening, choose quad screen. Your doctor can recommend based on your age, risk factors, and preferences.

Does a positive screening result mean my baby has a condition?

No. Both tests are screening tests that estimate risk, not diagnose. A positive result means further evaluation is needed — typically genetic counseling and possibly amniocentesis or CVS for definitive diagnosis. Most positive screening results are false positives, especially with NIPT.

Can I do both NIPT and quadruple screening?

Yes, some women choose both — NIPT for highly accurate chromosomal screening and quad screen for neural tube defect detection. Alternatively, NIPT plus a detailed ultrasound anatomy scan provides comprehensive coverage. Your doctor can advise on the best combination for your situation.

Is NIPT available outside Kathmandu?

NIPT is primarily available through private laboratories in Kathmandu, with some samples sent to reference laboratories. Quadruple screening is more widely available across Nepal. For patients outside the Valley, sample collection and referral arrangements can often be made — ask your doctor or the laboratory about options.

What if I cannot afford NIPT?

Quadruple screening offers good screening at a much lower cost (Rs. 2,000–4,000) and is an excellent alternative for average-risk pregnancies. Detailed ultrasound anatomy scans also provide important structural screening. Discuss budget constraints with your doctor — they can help you choose the most appropriate option within your means.

Does NIPT test for neural tube defects?

Standard NIPT does not screen for neural tube defects. The quadruple screen detects them through AFP measurement, and detailed ultrasound anatomy scans can also identify neural tube defects structurally. If neural tube defect screening is important to you, the quad screen or ultrasound provides that coverage that NIPT lacks.

Are these tests safe for me and the baby?

Both tests require only a maternal blood draw — completely safe for mother and baby with no risk to the pregnancy. This is a major advantage over diagnostic tests like amniocentesis which involve sampling and carry a small procedure-related risk. Screening tests are the safe first step before considering invasive diagnosis.

What happens after a positive screening result?

You will be referred for genetic counseling to understand what the result means, then offered diagnostic testing — typically amniocentesis or CVS — for definitive diagnosis. Most positive screening results do not indicate an affected pregnancy. The counseling helps you understand risks and make informed decisions about next steps.

Still have questions? Contact us or book an appointment for personalized guidance.

Related Services & Guides

Related Health Guides

Medical Review & Sources

Medically reviewed by: Thamel Clinic Clinical Team (MBBS, MD)

Role: Prenatal screening and maternal-fetal medicine reviewers, Thamel Clinic, Kathmandu

Last reviewed: 2026-11-08

Reviewed against current prenatal screening guidelines. This is general medical information; a registered clinician must assess each patient before diagnosis or treatment decisions.

View clinic team and credentials

Medical information is general guidance only and does not replace an individual consultation. Treatment decisions are made after clinical assessment, including allergy and pregnancy review.

Medical Disclaimer

Important information about using this medical website

Educational Purpose Only

The information provided on this website, including all text, graphics, images, and other material, is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment.

No Doctor-Patient Relationship

Use of this website does not create a doctor-patient relationship. The information provided is not tailored to your specific medical condition or health needs. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Emergency Situations

If you think you may have a medical emergency, call your doctor or emergency services immediately. In Nepal, call 102 for emergency services or go to the nearest hospital emergency room.

Emergency Contact Information:

National Emergency:

102 (Ambulance)

Our Clinic:

+977-9700682800 (WhatsApp available 24/7)

Bir Hospital Emergency:

+977-1-4412400

TU Teaching Hospital:

+977-1-4434320

Timeliness of Information

Medical information changes rapidly. While we strive to provide current and accurate information, we make no guarantees about the completeness, accuracy, reliability, suitability, or availability with respect to the website or the information contained on the website.

Professional Medical Advice Required

Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you have any specific questions about any medical matter, you should consult your doctor or other professional healthcare provider.

Treatment and Diagnosis

Do not use the information on this website to diagnose or treat any health problem or disease. The descriptions of treatments and medications provided are for general informational purposes only and do not constitute medical advice.

Limitation of Liability

In no event shall we be liable for any loss or damage arising from the use of this website or reliance on the information provided herein. This includes, but is not limited to, direct, indirect, incidental, punitive, and consequential damages.

Nepal-Specific Considerations

This website is operated in Nepal and is intended for users in Nepal. The medical information provided may not be applicable to healthcare systems outside Nepal. Always consult with local healthcare providers familiar with Nepal's healthcare system and regulations.

Last Updated: November 20, 2026 |Clinic: Thamel Clinic |Licensed: Registered

WhatsAppBook Now